Sam Cooper
Vice President, Business Development, Cell and Gene,
Cardinal Health
Driving strategy, operational growth, and innovative services for next-gen therapies. With expertise in strategy and commercial operations, he has led many transformative initiatives.
Previously, Sam was a leader at Deloitte Consulting's Life Sciences practice, advising healthcare organizations on strategic and operational challenges. He also held roles in corporate strategy, sales, and engineering at Robert Bosch.
Sessions
-
10-Feb-2026Theatre 4From source to stability: Ensuring supply chain resilience amidst disruption